Showing results (1881-1890 of 4,401) with videos related to
Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|November 17, 2022
A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic PropertiesLeonhard H F Köhler, Sebastian Reich, Maria Yusenko, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Novel Cyclopentapyrrole Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and HypersomniaRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK PropertiesZhaobing Xu, Qi Xiao, Yong Liu, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological CancerRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Isohexide Bisglycolamides as Inhibitors of the Integrated Stress ResponseVincent J Colandrea, Amruta Joshi-Pangu, Robert T Nolte, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Enthalpy-Entropy Trade-Off Underlies Geometric Isomer Selectivity in Histamine H1 Receptor-Doxepin InteractionHiroto Kaneko, Satoru Nagatoishi, Kouhei Tsumoto, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.ACS Medicinal Chemistry Letters|February 18, 2026
From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic TherapeuticsAnna C Renner, Robert B KargboACS Medicinal Chemistry Letters|February 18, 2026
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid SeriesGiovanni Ferrandi, Greta Bagnolini, Laura Poppi, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory DiseasesRam W SabnisPageof 441